LGALS9 and breast cancer: In this study, stable genetic KD of Gal-9 directly in MDA-MB-231 breast cancer cells reduced tumor cell adhesion to, and invasion through, ECM-coated plates and transwells, respectively, versus scrambled shRNA controls.